We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Researchers Will Have Ready Access to Molecular Diagnostics Expertise at the AACC Clinical Lab Expo

By LabMedica International staff writers
Posted on 30 Jul 2013
Print article
Image: Nebsolutions expertise promotes molecular diagnostic development (Photo courtesy of New England Biolabs).
Image: Nebsolutions expertise promotes molecular diagnostic development (Photo courtesy of New England Biolabs).
Biotech and other life science researchers will be able to consult with a team of molecular diagnostics (MDx) experts at the AACC (American Association for Clinical Chemistry) Clinical Lab Expo in Houston (TX, USA), from July 30-August 1, 2013.

The New England Biolabs (Ipswich, MA, USA) NEBsolutions team of experts will be available at booth 4463 during the Lab Expo meeting. The team is in place to direct access to expertise in enzymology, supply logistics, custom formulations, packaging, and kit development and to maximize access to New England Biolabs' catalogue of high-quality reagents. New England Biolabs provides reagents for a variety of MDx applications, such as sample preparation, PCR, RT-PCR, isothermal amplification, methylation detection, and library preparation for next generation sequencing.

NEBsolutions, a dedicated team within the New England Biolabs framework, comprises 110 PhDs, more than half with greater than 10 years of tenure at New England Biolabs. They provide the highest level of support to meet the specific needs of New England Biolabs' OEM and customized product customers. The NEBsolutions team excels at meeting aggressive timelines and offers rapid lead-times. This includes leveraging the capabilities of the entire company to help customers achieve their goals. The NEBsolutions team will work to optimize reagent formulation, function, and manufacturing process, resulting in an optimized product while minimizing cost.

"New England Biolabs has been supplying high-quality reagents to the molecular diagnostics community since 1995," said John Pelletier, director of NEBsolutions. "Through the NEBsolutions team, you gain access to NEB’s broad array of resources, including the deep scientific know-how to functionally optimize your product, comprehensive experience in the manufacturing of high-quality products, and extensive experience in supply chain management and risk mitigation. Our quality-by-design approach ensures product performance and consistency that surpass customer needs."

Related Links:
New England Biolabs
NEBsolutions


Gold Supplier
SARS-CoV-2 Multiplex Real-Time RT-PCR Assay
GSD NovaPrime Plus SARS-CoV-2
New
Molecular Diagnostic System
FlashDetect Flash48
New
Benchtop Centrifuge & Vortexer
ExiSpin
New
Gold Supplier
NT-proBNP Quantitative Antigen Test
NT-proBNP-CHECK-1

Print article

Channels

Industry

view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.